HIV/AIDS

Guidelines on the public health response to pretreatment HIV drug resistance

Supplement to the 2016 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: second edition June 2016

Authors:
WHO

Guidelines on the public health response to pretreatment HIV drug resistance

Publication details

Number of pages: 84
Publication date: July 2017
Languages: English
ISBN: ISBN 978-92-4-155005-5

Downloads

Overview

This publication provides guidance on the public health response to pretreatment HIV drug resistance (HIVDR) to non-nucleoside reverse-transcriptase inhibitors (NNRTIs) among people without prior antiretroviral (ARV) drug exposure or people with prior ARV exposure who are initiating or reinitiating first-line antiretroviral therapy (ART).

It also provides the consensus prevalence or threshold of pretreatment HIVDR to NNRTIs at which specific public health actions are triggered. This publication is a supplement to Chapter 4 of the 2016 WHO consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection (2016 WHO consolidated ARV guidelines).

Related links